BTG3 and synovial sarcoma: Similarly, Wnt1- and Wnt3a-positive SS patients and Wnt1- and Wnt3a-negative SS patients were not significantly different with regard to ANA, anti-Ro, and anti-La antibody positivity (for each p > 0.05) (Table 3).